Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros











Intervalo de año de publicación
1.
Int J Oral Sci ; 9(3): 158-166, 2017 09.
Artículo en Inglés | MEDLINE | ID: mdl-28960195

RESUMEN

Doxycycline (DOX) exhibits anti-inflammatory and MMP inhibitory properties. The objectives of this study were to evaluate the effects of DOX on alveolar bone repair. Controls (CTL) and DOX-treated (10 and 25 mg·kg-1) molars were extracted, and rats were killed 7 or 14 days later. The maxillae were processed and subjected to histological and immunohistochemical assays. Hematoxylin-eosin staining (7th day) revealed inflammation in the CTL group that was partly reversed after DOX treatment. On the 14th day, the CTL group exhibited bone neoformation, conjunctive tissue, re-epithelization and the absence of inflammatory infiltrate. DOX-treated groups exhibited complete re-epithelization, tissue remodelling and almost no inflammation. Picrosirius red staining in the DOX10 group (7th and 14th days) revealed an increased percentage of type I and III collagen fibres compared with the CTL and DOX25 groups. The DOX10 and DOX25 groups exhibited increases in osteoblasts on the 7th and 14th days. However, there were fewer osteoclasts in the DOX10 and DOX25 groups on the 7th and 14th days. Wnt-10b-immunopositive cells increased by 130% and 150% on the 7th and 14th days, respectively, in DOX-treated groups compared with the CTL group. On the 7th day, Dickkopf (Dkk)-1 immunostaining was decreased by 63% and 46% in the DOX10 and DOX25 groups, respectively. On the 14th day, 69% and 42% decreases in immunopositive cells were observed in the DOX10 and DOX25 groups, respectively, compared with the CTL group. By increasing osteoblasts, decreasing osteoclasts, activating Wnt 10b and neutralising Dkk, DOX is a potential candidate for bone repair in periodontal diseases.


Asunto(s)
Proceso Alveolar/efectos de los fármacos , Remodelación Ósea/efectos de los fármacos , Doxiciclina/farmacología , Vía de Señalización Wnt/efectos de los fármacos , Cicatrización de Heridas/efectos de los fármacos , Animales , Modelos Animales de Enfermedad , Técnicas para Inmunoenzimas , Masculino , Diente Molar/cirugía , Osteoblastos/efectos de los fármacos , Osteoclastos/efectos de los fármacos , Ratas , Ratas Wistar , Extracción Dental
2.
Periodontia ; 22(3): 70-74, 2012. graf
Artículo en Inglés | LILACS, BBO - Odontología | ID: lil-728150

RESUMEN

Gingivitis is an inflammation of dental protective tissues and biofilm accumulation is the main etiologic factor of this disease. Due to the antimicrobial and anti-inflammatory actions shown by Ocimum gratissimum (OCG), this study aimed at evaluating the antiplaque and antigingivitis effect of 3% OCG gel in human gingivitis. Thirty volunteers were selected and subdivided in 2 groups (n=15): control (placebo gel+brushing), and test (3% OCG gel+brushing). All participants received mouth guards to apply the gel 3 times/day during 15 days. Visible Plaque Index (VPI= mean±sd %), Turesky Index (TUR= mean scores±sd) and Gingival bleeding Index (GI= mean±sd %) were performed on days 0 and 15. All the individuals, with mean age of 21.8 years, being 50% females, completed the study. In both groups, control and test, there was a reduction (p<0.05) on VPI of 51.9% and 65.1%, respectively, when compared to each respective baseline. Test showed lower VPI (p<0.05) when compared to control. TUR index corroborated VPI findings. Both experimental groups presented a decrease by 68.4% when compared to its respective baseline. Control and test groups showed reduction on GI of 59.38% and 80.9%, respectively, when compared to baseline. A greater reduction was observed in the use of 3% gel when compared to control (p<0.05). The present study indicates that 3% OCG gel associated to brushing showed antiplaque and antigingivitis effect, being important as an adjuvant to plaque-induced gingivitis treatment


Asunto(s)
Gingivitis , Placa Dental
3.
Rev. dor ; 11(1)jan.-mar. 2010.
Artículo en Portugués | LILACS | ID: lil-562432

RESUMEN

BACKGROUND AND OBJECTIVES: Stimulations with formalin in the orofacial region can be related to transient or subacute nociceptive activity and behavioral changes. The evaluation of behavioral changes induced by persistent or chronic irritating nociceptive substance has not yet been described.METHOD: Complete Freund's Adjuvant (CFA) was injected in the temporomandibular joint (TMJ) region of rats and analyzed comparing it to the groups treated with saline and 2.5% formalin. In addition, behaviors such as grooming, freezing, rest/sleeping and chewing-like were electronically observed and quantified.RESULTS: It was shown that the chewing-like behavior was significantly increased and that it was inhibited by indometacin (5 mg/kg) and morphine (4 mg/kg). CONCLUSION: These results suggest that chewing-like may be a possible behavior of persistent or chronic orofacial pain, and may be a tool for clinical-pharmacological studies.


JUSTIFICATIVA E OBJETIVOS: Estímulos com formalina na região orofacial podem estar relacionados com a atividade nociceptiva e as alterações comportamentais transitórias ou subagudas. A avaliação de comportamentos sob ação de substância irritante nociceptiva persistente e crônica ainda não foi descrita.MÉTODO: Foi feita injeção de adjuvante completo de Freund (ACF) na região da articulação temporomandibular (ATM) de ratos e foi analisada comparando-a com os grupos tratados com salina e formalina a 2,5%. Além disso, foram observados e quantificados eletronicamente os comportamentos grooming, freezing, rest/sleeping e chewing-like (mastigação). RESULTADOS: Observou-se que o comportamento mastigação (chewing-like) estava significativamente aumentado e que ele foi inibido pela indometacina (5 mg/kg) e morfina (4 mg/kg).CONCLUSÃO: Esses resultados sugerem ser o chewing-like um possível comportamento de dor orofacial persistente, oferecendo-se como instrumento para análise clínico-farmacológica


Asunto(s)
Animales , Masculino , Ratas , Analgésicos/farmacología , Dolor Facial/fisiopatología , Masticación/efectos de los fármacos , Trastornos de la Articulación Temporomandibular/fisiopatología , Analgésicos Opioides/uso terapéutico , Anestésicos Locales/uso terapéutico , Antiinflamatorios no Esteroideos/uso terapéutico , Conducta Animal , Modelos Animales de Enfermedad , Adyuvante de Freund , Indometacina/uso terapéutico , Lidocaína/uso terapéutico , Morfina/uso terapéutico , Ratas Wistar , Trastornos de la Articulación Temporomandibular/inducido químicamente
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA